Division of Endocrinology, Metabolism and Nephrology Department of Internal Medicine, Keio University School of Medicine, Hanamachi, Shinjuku-ku, Japan.
Division of Endocrinology, Metabolism and Nephrology Department of Internal Medicine, Keio University School of Medicine, Hanamachi, Shinjuku-ku, Japan,
Blood Purif. 2021;50(3):380-389. doi: 10.1159/000511293. Epub 2020 Oct 22.
The incremental shuttle walking test (ISWT) is an important marker of aerobic capacity in patients on peritoneal dialysis (PD). This study aimed to evaluate its predictive value for PD-related outcomes.
This single-center cohort study recruited outpatients on maintenance PD from our hospital between March 2017 and March 2018. Exercise capacity was assessed using measurement of ISWT and handgrip and quadriceps strength. Patients were divided into 2 groups according to the median of exercise capacity and prospectively followed up until cessation of PD, death, or the study end (October 2019). The primary end point of this study was technique survival rate, and secondary outcomes were rates of peritonitis-free survival and PD-related hospitalization-free survival.
Among the 50 participants, age and PD vintage were [median (IQR)] 62.5 (58.3-70) and 3.5 (1.3-6.5) years, respectively. At the end of the study, 3 of the 28 participants (11%) in the long-ISWT group and 13 of the 22 participants (59%) in the short-ISWT group were transferred to hemodialysis. The short-ISWT group showed lower technique survival rate (p < 0.001), peritonitis-free survival rate (p = 0.01), and PD-related hospitalization-free survival rate (p < 0.01) than the long-ISWT group, whereas those survival rates did not differ when participants were divided by handgrip or quadriceps strength. Multivariate analysis revealed lower ISWT to be independently associated with technique failure (p = 0.002).
The ISWT is an important predictor of technique survival for patients on PD. Monitoring and enhancing ISWT as a marker of aerobic capacity might improve PD-related outcomes.
递增式 shuttle 步行试验(ISWT)是腹膜透析(PD)患者有氧能力的重要标志物。本研究旨在评估其对 PD 相关结局的预测价值。
本单中心队列研究纳入了 2017 年 3 月至 2018 年 3 月期间在我院接受维持性 PD 的门诊患者。通过 ISWT 以及握力和股四头肌力量测量来评估运动能力。根据运动能力的中位数,将患者分为 2 组,并前瞻性随访至 PD 终止、死亡或研究结束(2019 年 10 月)。本研究的主要终点是技术生存率,次要结局是腹膜炎无生存率和 PD 相关住院无生存率。
在 50 名参与者中,年龄和 PD 年限分别为[中位数(IQR)]62.5(58.3-70)和 3.5(1.3-6.5)年。研究结束时,28 名长 ISWT 组患者中有 3 名(11%)和 22 名短 ISWT 组患者中有 13 名(59%)转为血液透析。与长 ISWT 组相比,短 ISWT 组的技术生存率(p < 0.001)、腹膜炎无生存率(p = 0.01)和 PD 相关住院无生存率(p < 0.01)较低,而当根据握力或股四头肌力量将参与者分组时,这些生存率没有差异。多变量分析显示,较低的 ISWT 与技术失败独立相关(p = 0.002)。
ISWT 是 PD 患者技术生存率的重要预测指标。监测和增强 ISWT 作为有氧能力的标志物可能改善 PD 相关结局。